Literature DB >> 32632467

Carcinoma of unknown primary with hepatic metastases: a need of judicious and contemplative diagnostic algorithm.

Vikram Sai Shivaji1, Joseph Charles Wilson2, Noemi L Schmidt3, Orpheus Kolokythas4, Neeraj Lalwani5.   

Abstract

Carcinoma of Unknown Primary presenting primarily as hepatic metastases encompasses a dismal subgroup of tumors with a median survival of 5.9 months. Adenocarcinoma is the most common histological subtype identified upon biopsy and the primary tumor remains undetectable in the majority of cases despite extensive workup. It is important to have a validated and standardized algorithm to follow these tumors to avoid unnecessary tests, as the wishes and health status of the patient represent the principal concerns. The purpose of this paper is to briefly review the current literature on carcinoma of unknown primary with hepatic metastases and propose a standardized diagnostic approach.

Entities:  

Keywords:  Carcinoma of unknown primary; Hepatic metastases; Molecular profiling

Mesh:

Year:  2020        PMID: 32632467     DOI: 10.1007/s00261-020-02630-3

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  46 in total

1.  Epidemiology of unknown primary tumours.

Authors:  F Levi; V C Te; G Erler; L Randimbison; C La Vecchia
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162

2.  Hepatic metastases from an unknown primary neoplasm (UPN): survival, prognostic indicators and value of extensive investigations.

Authors:  B A Hogan; F J Thornton; M Brannigan; T J Browne; S Pender; P O'Kelly; S M Lyon; M J Lee
Journal:  Clin Radiol       Date:  2002-12       Impact factor: 2.350

Review 3.  Individual life expectancy estimation using validated prognostic scores for patients with cancer of unknown primary.

Authors:  Charles Ferté; Nicolas Penel; Jacques Bonneterre; Antoine Adenis
Journal:  Oncology       Date:  2010-03-30       Impact factor: 2.935

4.  Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma.

Authors:  K R Hess; M C Abbruzzese; R Lenzi; M N Raber; J L Abbruzzese
Journal:  Clin Cancer Res       Date:  1999-11       Impact factor: 12.531

5.  An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.

Authors:  Richard W Tothill; Adam Kowalczyk; Danny Rischin; Alex Bousioutas; Izhak Haviv; Ryan K van Laar; Paul M Waring; John Zalcberg; Robyn Ward; Andrew V Biankin; Robert L Sutherland; Susan M Henshall; Kwun Fong; Jonathan R Pollack; David D L Bowtell; Andrew J Holloway
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

Review 6.  Cancer of unknown primary (CUP).

Authors:  Nicholas Pavlidis; Karim Fizazi
Journal:  Crit Rev Oncol Hematol       Date:  2005-06       Impact factor: 6.312

7.  Unknown primary tumors metastatic to liver.

Authors:  J P Ayoub; K R Hess; M C Abbruzzese; R Lenzi; M N Raber; J L Abbruzzese
Journal:  J Clin Oncol       Date:  1998-06       Impact factor: 44.544

8.  Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients.

Authors:  J L Abbruzzese; M C Abbruzzese; K R Hess; M N Raber; R Lenzi; P Frost
Journal:  J Clin Oncol       Date:  1994-06       Impact factor: 44.544

Review 9.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

Review 10.  Parallel progression of primary tumours and metastases.

Authors:  Christoph A Klein
Journal:  Nat Rev Cancer       Date:  2009-04       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.